Imamura Chiyo 今村知世

… Alternative Names

今村知世イマムラチヨ

IMAMURA Chiyo 今村知世

Less

Researcher Number	00570954
Other IDs
Affiliation (Current)	2025: 地方独立行政法人埼玉県立病院機構埼玉県立がんセンター(臨床腫瘍研究所), 病院遺伝科, 研究員 2025: 昭和大学, 大学共同利用機関等の部局等, 客員教授
Affiliation (based on the past Project Information) *help	2023: 昭和大学, 大学共同利用機関等の部局等, 准教授 2018 – 2020: 昭和大学, 大学共同利用機関等の部局等, 准教授 2016 – 2018: 慶應義塾大学, 医学部(信濃町), 講師 2010 – 2012: 慶應義塾大学, 医学部, 講師
Review Section/Research Field	Principal Investigator Basic Section 47060:Clinical pharmacy-related / Applied pharmacology / Medical pharmacy Except Principal Investigator Respiratory organ internal medicine
Keywords	Principal Investigator PK規定因子 / 循環腫瘍DNA(ctDNA) / 腫瘍量 / ラムシルマブ / 循環腫瘍DNA (ctDNA) / 標的抗原/受容体量 / 薬物動態規定因子 / 抗体製剤 / exposure matching / 個別化投薬 … More / がん薬物療法 / 薬物動態 / 薬物曝露量 / 個別化投与 / 癌 / PK/PD解析 / ｵｰﾀﾞｰﾒｲﾄﾞ医療 / 臨床 / 薬学 / がん / 非小細胞肺がん / ドセタキセル / 高齢者 / スペシャル・ポピュレーション / 抗がん剤 / PK/PD 解析 / オーダーメイド医療 … More Except Principal Investigator 薬理学 / 癌 / EGFRチロシンキナーゼ阻害剤 / 臨床薬理学 / 非小細胞肺癌 Less

Exploration for determinant of PK for monoclonal antibodies targeting antigen/receptor expressed on tumor cellsPrincipal Investigator
- Principal Investigator
  
  今村知世
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Showa University
Development of individualized medicine by exposure matching based on key determinant of pharmacokineticsPrincipal Investigator
- Principal Investigator
  
  IMAMURA Chiyo
- Project Period (FY)
  2017 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Applied pharmacology
- Research Institution
  Showa University
  Keio University
Therapeutic drug monitoring of EGFR-KIs for non-small cell lung cancer patients
- Principal Investigator
  
  Hirotsugu Kenmotsu
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Shizuoka Cancer Center Research Institute
Exploratory studyof dose adjustmentof oncologic drugs for special populationsPrincipal Investigator
- Principal Investigator
  
  IMAMURA Chiyo
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Keio University

All 2023 2021 2020 2019 2018 2017 2011 2010

All Journal Article Presentation Book

[Book] スペシャル・ポピュレーションへの抗がん薬用量調節ハンドブック2010
- Author(s)
  今村知世
- Total Pages
  203
- Publisher
  南山堂
- Data Source
  KAKENHI-PROJECT-22590142
[Journal Article] Prospective evaluation and refinement of an S-1 dosage formula based on renal function for clinical application.2021
- Author(s)
  Takeuchi M, Imamura CK, Booka E, Takeuchi H, Mizukami T, Kawakami T, Funakoshi T, Wakuda K, Aoki Y, Hamamoto Y, Kitago M, Kawakubo H, Boku N, Tanigawara Y, Kitagawa Y.
- Journal Title
  
  Cancer Science
  
  Volume: 112 Issue: 2 Pages: 751-759
- DOI
  10.1111/cas.14758
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08961
[Journal Article] A phase II study of regorafenib with a lower starting dose in patients with metastatic colorectal cancer: exposure-toxicity analysis of unbound regorafenib and its active metabolites (RESET Trial).2020
- Author(s)
  Suzuki T, Sukawa Y, Imamura CK, Masuishi T, Satake H, Kumekawa Y, Funakoshi S, Kotaka M, Horie Y, Kawai S, Okuda H, Terazawa T, Kondoh C, Kato K, Yoshimura K, Ishikawa H, Hamamoto Y, Boku N, Takaishi H, Kanai T.
- Journal Title
  
  Clinical Colorectal Cancer
  
  Volume: 19 Issue: 1 Pages: 13-21
- DOI
  10.1016/j.clcc.2019.10.004
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K08961
[Journal Article] がん薬物療法における情報収集・評価・提供2010
- Author(s)
  今村知世
- Journal Title
  
  薬事 11 月臨時増刊号
  
  Volume: 52巻 Pages: 113-120
- Data Source
  KAKENHI-PROJECT-22590142
[Journal Article] がん薬物療法における情報収集・評価・提供2010
- Author(s)
  今村知世
- Journal Title
  
  薬事11月臨時増刊号
  
  Volume: VOL.52 Pages: 113-120
- Data Source
  KAKENHI-PROJECT-22590142
[Presentation] 抗がん薬のPK規定因子を指標とした個別化投与の確立2023
- Author(s)
  今村　知世
- Organizer
  日本医療薬学会年会
- Invited
- Data Source
  KAKENHI-PROJECT-23K06216
[Presentation] Prospective evaluation of a developed S-1 dosage formula based on renal function.2019
- Author(s)
  Mizukami T, Takeuchi M, Imamura CK, Booka E, Takeuchi H, Kawakami T, Funakoshi T, Wakuda K, Aoki Y, Hamamoto Y, Kitago M, Kawakubo H, Boku N, Tanigawara Y, Kitagawa Y
- Organizer
  ASCO Gastrointestinal Cancers Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K08961
[Presentation] Exposure-response analysis of S-1 in patients with advanced gastric cancer.2019
- Author(s)
  Takeuchi M, Imamura CK, Booka E, Kasai H, Kawakubo H, Boku N, Tanigawara Y, Kitagawa Y.
- Organizer
  第17回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-17K08961
[Presentation] 腎機能に基づくS-1用量算出式「B-B formula」の検証試験2019
- Author(s)
  竹内優志，今村知世，坊岡英祐，竹内裕也，水上拓郎，川上武志，浜本康夫，川久保博文，朴成和，谷川原祐介，北川雄光
- Organizer
  第52回制癌剤適応研究会
- Data Source
  KAKENHI-PROJECT-17K08961
[Presentation] Exposure-toxicity analysis of unbound regorafenib and its active metabolites by dose escalation strategy with low starting dose in patients with colorectal cancer.2019
- Author(s)
  Satake H, Suzuki T, Imamura CK, Sukawa Y, Satake H, Kumekawa Y, Funakoshi S, Kotaka M, Horie Y, Kawai S, Okuda H, Terazawa T, Kondoh C, Kato K, Yoshimura K, Ishikawa H, Hamamoto Y, Boku N, Takaishi H, Kanai T.
- Organizer
  AACR Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K08961
[Presentation] Prospective evaluation of regorafenib dose escalation strategy with low starting dose in patients with colorectal cancer.2018
- Author(s)
  Masuishi T, Suzuki T, Sukawa Y, Imamura CK, Satake H, Kumekawa Y, Funakoshi S, Kotaka M, Horie Y, Kawai S, Okuda H, Terazawa T, Kondoh H, Kato K, Yoshimura K, Ishikawa H, Hamamoto Y, Boku N, Kanai T, Takaishi H
- Organizer
  ESMO 2018 Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K08961
[Presentation] 腎障害患者における抗がん薬のPK/PDと用量調節2017
- Author(s)
  今村知世
- Organizer
  第9回日本がん薬剤師学会
- Invited
- Data Source
  KAKENHI-PROJECT-17K08961
[Presentation] Prospective evaluation of the relationship between erlotinib concentration and efficacy in patients with non-small cell lung cancer harboring EGFR-activating mutations.2017
- Author(s)
  Hirotsugu Kenmotsu, Chiyo K. Imamura, Takahisa Kawamura, Takuya Oyakawa, Shota Omori, Kazuhisa Nakashima, Kazushige Wakuda, Akira Ono, Tetsuhiko Taira, Tateaki Naito, Haruyasu Murakami, Nobuyuki Yamamoto, Toshiaki Takahashi and Yusuke Tanigawara
- Organizer
  ESMO 2017 Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09568
[Presentation] 抗がん薬の臨床薬理2017
- Author(s)
  今村知世
- Organizer
  第55回日本癌治療学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-17K08961
[Presentation] Impact of CYP2C19 polymorphisms on the pharmacokinetics of tacrolimus when co-administered with voriconazole2017
- Author(s)
  今村知世
- Organizer
  15th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K08961
[Presentation] スペシャル・ポピュレーションに対する用量調節2011
- Author(s)
  今村知世
- Organizer
  第49回日本癌治療学会学術集会
- Place of Presentation
  名古屋国際会議場(愛知県)
- Year and Date
  2011-10-28
- Data Source
  KAKENHI-PROJECT-22590142
[Presentation] 肝機能低下患者に対する抗がん薬の用量調節2011
- Author(s)
  今村知世
- Organizer
  第9回日本臨床腫瘍学会学術集会
- Place of Presentation
  パシフィコ横浜(神奈川県)
- Year and Date
  2011-07-23
- Data Source
  KAKENHI-PROJECT-22590142
[Presentation] 肝機能低下患者に対する抗がん薬の用量調節2011
- Author(s)
  今村知世
- Organizer
  第9回日本臨床腫瘍学会学術集会
- Place of Presentation
  パシフィコ横浜(神奈川県)(招待講演)
- Year and Date
  2011-07-23
- Data Source
  KAKENHI-PROJECT-22590142
[Presentation] スペシャル・ポピュレーションに対する用量調節2011
- Author(s)
  今村知世
- Organizer
  第49回日本癌治療学会学術集会
- Place of Presentation
  名古屋国際会議場(愛知県)(招待講演)
- Year and Date
  2011-10-28
- Data Source
  KAKENHI-PROJECT-22590142
[Presentation] がん化学療法の有効性・安全性確保に向けた関わり2010
- Author(s)
  今村知世
- Organizer
  第69回日本癌学会学術総会「シンポジウム:がん薬物療法の向上のための Pharmacy Specialist の関わり」
- Place of Presentation
  大阪国際会議場
- Year and Date
  2010-09-23
- Data Source
  KAKENHI-PROJECT-22590142
[Presentation] がん化学療法の有効性・安全性確保に向けた関わり2010
- Author(s)
  今村知世
- Organizer
  第69回日本癌学会学術総会「シンポジウム:がん薬物療法の向上のためのPharmacy Specialistの関わり」
- Place of Presentation
  大阪国際会議場
- Year and Date
  2010-09-23
- Data Source
  KAKENHI-PROJECT-22590142

1. TANIGAWARA Yusuke (30179832)

# of Collaborated Projects: 3 results

# of Collaborated Products: 5 results
2. HIRASAWA Akira (90296658)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. Hirotsugu Kenmotsu (50602637)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
4. 平田賢郎 (40570932)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Imamura Chiyo 今村 知世

今村 知世 イマムラ チヨ

IMAMURA Chiyo 今村 知世

Research Projects

Research Products

Co-Researchers

Exploration for determinant of PK for monoclonal antibodies targeting antigen/receptor expressed on tumor cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of individualized medicine by exposure matching based on key determinant of pharmacokineticsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Therapeutic drug monitoring of EGFR-KIs for non-small cell lung cancer patients

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Exploratory studyof dose adjustmentof oncologic drugs for special populationsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] スペシャル・ポピュレーションへの抗がん薬用量調節ハンドブック2010

Author(s)

Total Pages

Publisher

Data Source

[Journal Article] Prospective evaluation and refinement of an S-1 dosage formula based on renal function for clinical application.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A phase II study of regorafenib with a lower starting dose in patients with metastatic colorectal cancer: exposure-toxicity analysis of unbound regorafenib and its active metabolites (RESET Trial).2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] がん薬物療法における情報収集・評価・提供2010

Author(s)

Journal Title

Data Source

[Journal Article] がん薬物療法における情報収集・評価・提供2010

Author(s)

Journal Title

Data Source

[Presentation] 抗がん薬のPK規定因子を指標とした個別化投与の確立2023

Author(s)

Organizer

Data Source

[Presentation] Prospective evaluation of a developed S-1 dosage formula based on renal function.2019

Author(s)

Organizer

Data Source

[Presentation] Exposure-response analysis of S-1 in patients with advanced gastric cancer.2019

Author(s)

Organizer

Data Source

[Presentation] 腎機能に基づくS-1用量算出式「B-B formula」の検証試験2019

Author(s)

Organizer

Data Source

[Presentation] Exposure-toxicity analysis of unbound regorafenib and its active metabolites by dose escalation strategy with low starting dose in patients with colorectal cancer.2019

Author(s)

Organizer

Data Source

[Presentation] Prospective evaluation of regorafenib dose escalation strategy with low starting dose in patients with colorectal cancer.2018

Author(s)

Organizer

Data Source

[Presentation] 腎障害患者における抗がん薬のPK/PDと用量調節2017

Author(s)

Organizer

Imamura Chiyo 今村知世

今村知世イマムラチヨ

IMAMURA Chiyo 今村知世